LBRX
LB Pharmaceuticals Inc Common Stock
There isn't enough reported data to score LBRX yet.
LBRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate LBRX's fundamentals.
LBRX PE Valuation
LBRX has no meaningful PE right now: it lost money over the past year.
LBRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| Moderate |
Analysts expect LBRX's losses to grow, with revenue holding steady.
LBRX Earnings Per Share
LBRX Quarterly Revenue
LBRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$38M | -$32.4M |
| Q1 2026 | -$23.3M | -$15.2M |
| Q2 2025 | -$5.6M | +$10.2M |
| Q1 2025 | -$8.1M | +$1.5M |
LBRX has burned cash in almost every quarter: −$144M over the past year, against −$52M the year before.
LBRX Net Leverage
LBRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LBRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 48.5 | Neutral |
LBRX's weekly RSI is 61 (neutral) and its Stochastic is 49 (neutral).
LBRX PE vs Healthcare Sector
LBRX has no meaningful PE right now: it lost money over the past year.
LBRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.9 | 9.2% above |
| 20 week MA | $40.6 | 4.6% above |
| 50 week MA | $31.4 | 35% above |
LBRX is in an uptrend: it's above all three of its weekly moving averages, and 35% above its 50-week average.
LBRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $16.8 | $21.5 | +28% |
| 2026 YTD | $21.5 | $42.5 | +97% |
LBRX has finished every year since 2025 higher, and it's up 97% so far in 2026.